Identifying Patients without a Survival Benefit following Transfemoral and Transapical Transcatheter Aortic Valve Replacement

Identifying Patients without a Survival Benefit following Transfemoral and Transapical Transcatheter Aortic Valve Replacement

Transcatheter aortic valve replacement (TAVR) offers a novel treatment option for patients with severe symptomatic aortic valve stenosis, particularly for patients who are unsuitable candidates for surgical intervention. However, high therapeutical costs, socio-economic considerations, and numerous...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daniela Geisler, Piotr Nikodem Rudziński, Waseem Hasan, Martin Andreas, Ena Hasimbegovic, Christopher Adlbrecht, Bernhard Winkler, Gabriel Weiss, Andreas Strouhal, Georg Delle-Karth, Martin Grabenwöger, Markus Mach
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
futility
TAVI
TAVR
SAVR
Medicine
R
Acceso en línea:https://doaj.org/article/55321a7b85814838b8f38e06ef310546
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares